Cargando…

Beta amyloid deposition and cognitive decline in Parkinson’s disease: a study of the PPMI cohort

The accumulation of beta amyloid in the brain has a complex and poorly understood impact on the progression of Parkinson’s disease pathology and much controversy remains regarding its role, specifically in cognitive decline symptoms. Some studies have found increased beta amyloid burden is associate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mihaescu, Alexander S., Valli, Mikaeel, Uribe, Carme, Diez-Cirarda, Maria, Masellis, Mario, Graff-Guerrero, Ariel, Strafella, Antonio P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472347/ https://www.ncbi.nlm.nih.gov/pubmed/36100909 http://dx.doi.org/10.1186/s13041-022-00964-1

Ejemplares similares

VMAT2 availability in Parkinson’s disease with probable REM sleep behaviour disorder
por: Valli, Mikaeel, et al.
Publicado: (2021)

Contributions of sex, depression, and cognition on brain connectivity dynamics in Parkinson’s disease
por: Diez-Cirarda, Maria, et al.
Publicado: (2021)

The Association of CSF sTREM2 With Cognitive Decline and Its Dynamic Change in Parkinson's Disease: Analysis of the PPMI Cohort
por: Qin, Qixiong, et al.
Publicado: (2022)

The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort
por: Marek, Kenneth, et al.
Publicado: (2018)

Risk factors of levodopa-induced dyskinesia in Parkinson’s disease: results from the PPMI cohort
por: Eusebi, Paolo, et al.
Publicado: (2018)

Extrastriatal (123)I-FP-CIT SPECT impairment in Parkinson’s disease – the PPMI cohort
por: Nicastro, Nicolas, et al.
Publicado: (2020)

Glucosylceramide in cerebrospinal fluid of patients with GBA-associated and idiopathic Parkinson’s disease enrolled in PPMI
por: Huh, Young Eun, et al.
Publicado: (2021)

Beta Amyloid Deposition Is Not Associated With Cognitive Impairment in Parkinson's Disease
por: Melzer, Tracy R., et al.
Publicado: (2019)

Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson’s disease: the PPMI cohort
por: Simuni, Tanya, et al.
Publicado: (2018)

MAO-B Polymorphism Associated with Progression in a Chinese Parkinson's Disease Cohort but Not in the PPMI Cohort
por: Cui, Shi-Shuang, et al.
Publicado: (2022)

Motor subtypes and clinical characteristics in sporadic and genetic Parkinson's disease groups: analysis of the PPMI cohort
por: Jeong, Eun Hye, et al.
Publicado: (2023)

Blood Neurofilament Light Chain in Parkinson’s Disease: Comparability between Parkinson’s Progression Markers Initiative (PPMI) and Asian Cohorts
por: Chen, Jia-Hung, et al.
Publicado: (2021)

Brain-predicted age in Down syndrome is associated with beta amyloid deposition and cognitive decline
por: Cole, James H., et al.
Publicado: (2017)

A test-retest study on Parkinson's PPMI dataset yields statistically significant white matter fascicles
por: Cousineau, Martin, et al.
Publicado: (2017)

Methodological considerations of evaluating the rate of presynaptic dopaminergic denervation in Parkinson disease with radiotracers: Analysis of the PPMI data
por: Lee, Jeong Won, et al.
Publicado: (2021)

Brain connectivity dynamics in cisgender and transmen people with gender incongruence before gender affirmative hormone treatment
por: Uribe, Carme, et al.
Publicado: (2021)

Peripheral immune cell imbalance is associated with cortical beta-amyloid deposition and longitudinal cognitive decline
por: Mehta, Neel H., et al.
Publicado: (2023)

Parameters from site classification to harmonize MRI clinical studies: Application to a multi‐site Parkinson's disease dataset
por: C. Monte‐Rubio, Gemma, et al.
Publicado: (2022)

Serial changes of I-123 FP-CIT SPECT binding asymmetry in Parkinson's disease: Analysis of the PPMI data
por: Jeong, Eun Hye, et al.
Publicado: (2022)

Reference LINE-1 insertion polymorphisms correlate with Parkinson’s disease progression and differential transcript expression in the PPMI cohort
por: Fröhlich, Alexander, et al.
Publicado: (2023)

Serum Uric Acid as a Putative Biomarker in Prodromal Parkinson’s Disease: Longitudinal Data from the PPMI Study
por: Koros, Christos, et al.
Publicado: (2023)

Dynamic functional connectivity in Parkinson's disease patients with mild cognitive impairment and normal cognition
por: Díez-Cirarda, María, et al.
Publicado: (2017)

Alteration of Tremor Dominant and Postural Instability Gait Difficulty Subtypes During the Progression of Parkinson's Disease: Analysis of the PPMI Cohort
por: Lee, Jeong Won, et al.
Publicado: (2019)

An Increased Burden of Highly Active Retrotransposition Competent L1s Is Associated with Parkinson’s Disease Risk and Progression in the PPMI Cohort
por: Pfaff, Abigail L., et al.
Publicado: (2020)

Patients with scans without evidence of dopaminergic deficit (SWEDD) do not have early Parkinson’s disease: Analysis of the PPMI data
por: Lee, Jeong Won, et al.
Publicado: (2021)

The Prejudice towards People with Mental Illness (PPMI) scale: structure and validity
por: Kenny, Amanda, et al.
Publicado: (2018)

Predicting miRNA-disease associations based on PPMI and attention network
por: Xie, Xuping, et al.
Publicado: (2023)

Network interdigitations of Tau and amyloid‐beta deposits define cognitive levels in aging
por: Kim, Chan‐Mi, et al.
Publicado: (2021)

Motor Synchronization to Rhythmic Auditory Stimulation (RAS) Attenuates Dopaminergic Responses in Ventral Striatum in Young Healthy Adults: [(11)C]-(+)-PHNO PET Study
por: Koshimori, Yuko, et al.
Publicado: (2019)

Plasma amyloid beta levels are associated with cerebral amyloid and tau deposition
por: Risacher, Shannon L., et al.
Publicado: (2019)

Early Life Obesity Increases Neuroinflammation, Amyloid Beta Deposition, and Cognitive Decline in a Mouse Model of Alzheimer’s Disease
por: So, Simon W., et al.
Publicado: (2023)

Serum albumin and beta-amyloid deposition in the human brain
por: Kim, Jee Wook, et al.
Publicado: (2020)

Inhalable Thioflavin S for the Detection of Amyloid Beta Deposits in the Retina
por: Barton, Shawn M., et al.
Publicado: (2021)

Plasma amyloid-beta oligomer is related to subjective cognitive decline and brain amyloid status
por: Kim, Keun You, et al.
Publicado: (2022)

Imaging biomarkers in Parkinson’s disease and Parkinsonian syndromes: current and emerging concepts
por: Saeed, Usman, et al.
Publicado: (2017)

Therapeutic Trem2 activation ameliorates amyloid-beta deposition and improves cognition in the 5XFAD model of amyloid deposition
por: Price, Brittani R., et al.
Publicado: (2020)

Efficacy of cognitive rehabilitation in Parkinson's disease
por: Díez-Cirarda, María, et al.
Publicado: (2018)

Preliminary Assessment of Reference Region Quantification and Reduced Scanning Times for [(18)F]SynVesT-1 PET in Parkinson's Disease
por: Smart, Kelly, et al.
Publicado: (2023)

Amyloid deposition in semantic dementia: a positron emission tomography study
por: Brown, Eric E., et al.
Publicado: (2016)

Amyloid- β and tau deposition influences cognitive and functional decline in Down syndrome
por: Grigorova, Monika, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1o15tdghbkqp2slj8ccujt1de4